- Tetradecylbenzyldimethylammonium chloride
- Barquat ms 100
- Benzyldimethylmyristylammonium chloride
- Benzyldimethyltetradecylammonium chloride
- n-Benzyl-n-Tetradecyldimethylammonium chloride
Surfactant and detergent.
Registry Numbers and Inventories.
R 22 36/38
Swiss Giftliste 1
Japan ENCS (MITI)
C23H42ClN . 2H2O
Melting point, °C
49 - 52
Solubility in water
> 1 g/L
Partition coefficient, pKow
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Strong oxidizing agents.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
CNS depression progressing to coma, seizures, shock, and respiratory muscle paralysis has been reported.
Vomiting, diarrhea and abdominal pain may occur. Ingestion of concentrated solutions may produce burns of the mouth, pharynx, and esophagus. Hemorrhagic gi tract necrosis and peritonitis have been reported.
Respiratory muscle paralysis, pulmonary edema, occupational asthma, and hypoxemia have been reported.
Dermal necrosis has resulted from exposure to cetrimonium bromide in concentrations ranging from 2 to 17.5 Percent. A number of these agents have caused irritant or allergic contact dermatitis.
Do not induce emesis - dilution: following ingestion and/or prior to gastric evacuation, immediately dilute with 4 to 8 ounces (120 to 240 ml) of milk or water (not to exceed 15 ml/kg in a child). The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Remove contaminated clothing, wash exposed area with copious amounts of water. A physician should examine the area if irritation or pain persists.
Eye exposure results in mild discomfort (0.1 Percent solution) to very serious corneal damage (1 to 10 percent solution) depending on the concentration. Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
2923 90 00